Macaca fascicularis papillomavirus type 1: a non-human primate betapapillomavirus causing rapidly progressive hand and foot papillomatosis

References

1. Berkhout R. J., Bouwes Bavinck J. N., ter Schegget J. 2000; Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 38:2087–2096
   [Google Scholar]
2. Chang F., Shen Q., Zhou J., Wang C., Wang D., Syrjänen S., Syrjänen K. 1990; Detection of human papillomavirus DNA in cytologic specimens derived from esophageal precancer lesions and cancer. Scand J Gastroenterol 25:383–388
   [Google Scholar]
3. Cowsert L. M., Lake P., Jenson A. B. 1987; Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. J Natl Cancer Inst 79:1053–1057
   [Google Scholar]
4. de Villiers E. M., Fauquet C., Broker T. R., Bernard H. U., zur Hausen H. 2004; Classification of papillomaviruses. Virology 324:17–27 [CrossRef]
   [Google Scholar]
5. Edgar R. C. 2004; muscle: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5:113 [CrossRef]
   [Google Scholar]
6. Fuchs P. G., Pfister H. 1997; Molecular biology of HPV and mechanisms of keratinocyte transformation. In Human Papillomavirus Infections in Dermatovenerology pp 15–46Edited by Gross G., von Krogh G. Boca Raton: CRC Press;
   [Google Scholar]
7. Gül U., Kilic A., Gönül M., Cakmak S. K., Bayis S. S. 2007; Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol 46:1069–1072 [CrossRef]
   [Google Scholar]
8. Hajdu S. I., Ali S. Z. 2008; Discovery of human papillomavirus in carcinoma of the lung. Ann Clin Lab Sci 38:3–5
   [Google Scholar]
9. Harwood C. A., Surentheran T., McGregor J. M., Spink P. J., Leigh I. M., Breuer J., Proby C. M. 2000; Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61:289–297 [CrossRef]
   [Google Scholar]
10. Hopfl R., Bens G., Wieland U., Petter A., Zelger B., Fritsch P., Pfister H. 1997; Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol 108:53–56 [CrossRef]
    [Google Scholar]
11. Howley P. M., Lowy D. R. 2007; Papillomaviruses. In Fields Virology , 5th edn. pp 2299–2354Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
12. Jablonska S., Dabrowski J., Jakubowicz K. 1972; Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 32:583–589
    [Google Scholar]
13. Jenson A. B., Geyer S., Sundberg J. P., Ghim S. 2001; Human papillomavirus and skin cancer. J Investig Dermatol Symp Proc 6:203–206 [CrossRef]
    [Google Scholar]
14. Lim P. S., Jenson A. B., Cowsert L., Nakai Y., Lim L. Y., Jin X. W., Sundberg J. P. 1990; Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J Infect Dis 162:1263–1269 [CrossRef]
    [Google Scholar]
15. Maggiorella M. T., Sernicola L., Crostarosa F., Belli R., Pavone-Cossut M. R., Macchia I., Farcomeni S., Tenner-Racz K., Racz P. other authors 2007; Multiprotein genetic vaccine in the SIV– Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection. J Med Primatol 36:180–194 [CrossRef]
    [Google Scholar]
16. McBride A. A., Byrne J. C., Howley P. M. 1989; E2 polypeptides encoded by bovine papillomavirus I form dimers through the carboxyl-terminal DNA binding domain: transactivation is mediated through the conserved amino-terminal domain. Proc Natl Acad Sci U S A 86:510–514 [CrossRef]
    [Google Scholar]
17. Orth G. 2006; Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 18:362–374 [CrossRef]
    [Google Scholar]
18. Orth G., Jablonska S., Jarzabek-Chorzelska M., Rzesa G., Obalek S., Favre M., Croissant O. 1979; Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 39:1074–1082
    [Google Scholar]
19. Pfister H., Fuchs P. G., Majewski S., Jablonska S., Pniewska I., Malejczyk M. 2003; High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 295:273–279 [CrossRef]
    [Google Scholar]
20. Psyrri A., DiMaio D. 2008; Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol 5:24–31 [CrossRef]
    [Google Scholar]
21. Ramoz N., Rueda L. A., Bouadjar B., Montoya L. S., Orth G., Favre M. 2002; Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579–581 [CrossRef]
    [Google Scholar]
22. Rector A., Bossart G. D., Ghim S. J., Sundberg J. P., Jenson A. B., Van Ranst M. 2004; Characterization of a novel close-to-root papillomavirus from a Florida manatee by using multiply primed rolling-circle amplification: Trichechus manatus latirostris papillomavirus type 1. J Virol 78:12698–12702 [CrossRef]
    [Google Scholar]
23. Schug J. 2008; Using tess to predict transcription factor binding sites in DNA sequence. In Current Protocols in Bioinformatics, chapter 2unit 2–6 New York: Wiley;
    [Google Scholar]
24. Schug J., Overton G. C. 1997; Modeling transcription factor binding sites with Gibbs sampling and minimum description length encoding. Proc Int Conf Intell Syst Mol Biol 5:268–271
    [Google Scholar]
25. Sundberg J. P., Reichmann M. E. 1993; Papillomavirus infections. In Nonhuman Primates II pp 1–8Edited by Jones T. C., Mohr U., Hunt R. D. Berlin: Springer;
    [Google Scholar]
26. Swofford D. L. 2002 paup*: Phylogenetic analysis using parsimony (and other methods), version 4 Sunderland, MA: Sinauer Associates;
    [Google Scholar]
27. Titolo S., Pelletier A., Sauve F., Brault K., Wardrop E., White P. W., Amin A., Cordingley M. G., Archambault J. 1999; Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin. J Virol 73:5282–5293
    [Google Scholar]
28. Tobler K., Favrot C., Nespeca G., Ackermann M. 2006; Detection of the prototype of a potential novel genus in the family Papillomaviridae in association with canine epidermodysplasia verruciformis. J Gen Virol 87:3551–3557 [CrossRef]
    [Google Scholar]
29. Van Doorslaer K., Rector A., Jenson A. B., Sundberg J. P., Van Ranst M., Ghim S. J. 2007; Complete genomic characterization of a murine papillomavirus isolated from papillomatous lesions of a European harvest mouse ( Micromys minutus ). J Gen Virol 88:1484–1488 [CrossRef]
    [Google Scholar]
30. Wilgenbusch J. C., Swofford D. 2003; Inferring evolutionary trees with paup*. In Current Protocols in Bioinformatics, chapter 6unit 6–4 New York: Wiley;
    [Google Scholar]
31. Wood C. E., Chen Z., Cline J. M., Miller B. E., Burk R. D. 2007; Characterization and experimental transmission of an oncogenic papillomavirus in female macaques. J Virol 81:6339–6345 [CrossRef]
    [Google Scholar]
32. Zheng Z. M., Baker C. C. 2006; Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11:2286–2302 [CrossRef]
    [Google Scholar]